2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part. (September 2015) - Hebbar, M.; Heurgue-Berlot, A.; Boige, V.; Le Malicot, K.; Bernard-Chabert, B.; Marcus, C.; Dharancy, S.; Sergent, G.; Perarnau, J.M.; Ehrhard, F.; Ollivier-Hourmand, I.; Vergniol, J.; et al.